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Background: Cystic fibrosis (CF) is characterized by recurrent respiratory infections and progressive lung disease.
Whereas exercise may contribute to preserving lung function, its benefit is difficult to ascertain given the selection
bias of healthier patients being more predisposed to exercise. Our objective was to examine the role of self-reported
exercise with longitudinal lung function and body mass index (BMI) measures in CF.
Methods: A total of 1038 subjects with CF were recruited through the U.S. CF Twin-Sibling Study. Questionnaires were
used to determine exercise habits. Questionnaires, chart review, and U.S. CF Foundation Patient Registry data were used
to track outcomes.
Results: Within the study sample 75% of subjects self-reported regular exercise. Exercise was associated with an older
age of diagnosis (p = 0.002), older age at the time of ascertainment (p < 0.001), and higher baseline FEV1 (p = 0.001),
but not CFTR genotype (p = 0.64) or exocrine pancreatic function (p = 0.19). In adjusted mixed models, exercise was
associated with both a reduced decline in FEV1 (p < 0.001) and BMI Z-score (p = 0.001) for adults, but not children
aged 10–17 years old.
Conclusions: In our retrospective study, self-reported exercise was associated with improved longitudinal nutritional
and pulmonary outcomes in cystic fibrosis for adults. Although prospective studies are needed to confirm these
associations, programs to promote regular exercise among individuals with cystic fibrosis would be beneficial.
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Cystic fibrosis (CF) is a life-limiting single gene disorder
caused by mutations in the cystic fibrosis transmem-
brane conductance regulator gene (CFTR) leading to
progressive lung function decline. As half of the vari-
ation in CF lung disease is secondary to non-genetic fac-
tors [1,2], examining the role of environmental factors is
critical in reducing the morbidity and mortality associ-
ated with CF. Although a number of factors have been
shown to have an impact on lung function in CF, includ-
ing secondhand smoke exposure [3-5], health insurance
[6-9], household income [10], adherence [11], air pollu-
tion [12], and ambient temperature [13], only two of
these are readily modifiable: secondhand smoke and* Correspondence: mcollac1@jhmi.edu
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unless otherwise stated.adherence. Another potential modifiable factor to im-
prove outcomes may be exercise.
There have been a number of well designed random-
ized controlled trials of exercise among individuals with
CF to determine the effects of exercise on lung function
and nutritional status. These trials, lasting from 1 week
to 3 years, have employed aerobic exercise, resistance
training, or a combination of both. Some studies have
demonstrated benefits to FEV1 [14,15], and some have
seen promising trends [16,17], while others have not
seen any benefit [18-20]. Similarly, some studies have
seen a benefit to FVC [15-18], while others have not
[14,19,20]. The mixed results of these studies may be re-
lated to the differing ages of participants or the differing
types and duration of exercise regimens utilized, al-
though it should be noted that no difference in FEV1
was seen in a 1 year trial of resistance training vs. aer-
obic training in CF. [21] Another reason for the differingLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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from 13 to 65 participants. A hypothetical study with 30
cases and 30 controls with an assumed baseline FEV1
percent predicted rate of decline of 2.0 ± 1.0% per year
would only have a statistical power of 62% to detect a
difference of 0.5% decline per year. However, a recent
larger prospective study of exercise in children with cys-
tic fibrosis (n = 212) did see an association between in-
creased habitual physical activity and a reduced decline
in FEV1 [22].
Many individuals with CF also have exocrine pancre-
atic insufficiency leading to lifelong malabsorption and
poor weight gain. Thus a potential concern is the in-
creased caloric expenditure resulting from exercise. Lim-
ited data suggest that individuals with CF expend more
energy with exercise than do healthy controls independ-
ent of baseline resting energy expenditures [23]. The re-
sults are mixed for the effects of exercise on nutritional
status in randomized controlled trials; at least one study
has seen benefits for body mass index (BMI) or ideal
weight-for-height for certain types of exercise [14], one
study observed a trend towards benefit [16], and other
studies have not seen any benefit [18-20].
In the absence of a larger randomized controlled trial,
we examined longitudinal respiratory and nutritional
outcomes in a large, well characterized sample of indi-
viduals with cystic fibrosis. Exercise was self-reported
representing a real-world scenario of asking patients
whether they participate in regular exercise. Using data
from the CF Twin-Sibling Study, we hypothesized that
exercise would be associated with a reduced decline in
lung function (FEV1) and improved nutritional status
(body mass index Z-scores) over time for individuals
who exercised compared to those who did not. Second-
ary analyses included assessing the prevalence of wheez-
ing in individuals who exercised versus those who did
not as we hypothesized that individuals reporting wheez-
ing with exercise would be less likely to participate in
exercise. Given our study sample size, we were also
able to examine whether specific subgroups of subjects
were more likely to benefit from exercise (i.e., males vs.
females, children vs. adults, etc.).
Methods
Study sample
All subjects were part of the CF Twin-Sibling Study
(n = 1038 individuals in 575 families) and were recruited
from CF centers in the United States (n = 952), Australia
(n = 48), Israel (n = 24), and United Kingdom (Scotland)
(n = 14) between 2000 and 2013 on the basis of having
CF and having a twin or sibling with CF. The CF Twin-
Sibling Study was designed to assess genetic and environ-
mental modifiers of clinical outcomes in CF. Written
consent was obtained from all subjects and the study wasapproved by the Johns Hopkins University Institutional
Review Board (Protocol #NA_00035659). Baseline ques-
tionnaires were obtained upon enrollment and in-
cluded (cross-sectional) questions on whether exercise
was routinely undertaken. English-language question-
naires included questions (Additional file 1: Table S1)
on whether various types of exercise were undertaken
(i.e., competitive, recreational, or both), which was tabu-
lated for subjects ≥10 years of age. The questionnaires
used are not validated and not age-specific; caregivers
routinely completed questionnaires for children less than
18 years of age.
Demographics
Age for each subject was defined by the date the ques-
tionnaire was completed. Race/ethnicity was self-defined
with subjects reporting any non-white ancestry defined
as non-white. Pancreatic sufficiency was defined by
genotype data (n = 911) as having one or more “pancreatic
sufficient” mutations, and by clinical data (n = 106) where
genotype data was indeterminate or not available. We
were unable to ascertain pancreatic function status for 21
subjects.
Outcome ascertainment
The presence or absence of wheezing with exertion was
defined by self-report. Pulmonary function test and body
mass index outcome data was collected through chart
review with data supplementation from the U.S. Cystic
Fibrosis Foundation Patient Registry. Longitudinal data
from non-U.S. locations were not necessarily available.
All raw FEV1 (liters) measurements were converted into
FEV1 percent predicted values as defined by the U.S. CF
Foundation [24,25]. Baseline FEV1 for a subject was de-
fined as the average FEV1 of all measurements obtained
the 12 months preceding or after the exercise question-
naire date. Change in lung function over time was
calculated from linear regression of all FEV1 percent
predicted measurements in the 5 years following ques-
tionnaire completion for subjects with a minimum of 4
FEV1 values taken over a period of no less than 2 years.
Body mass indices were converted into Z-scores using
CDC reference equations [26]. Baseline BMI Z-score and
change in BMI Z-score were calculated in a similar manner
to FEV1.
Statistical analysis
Differences in baseline characteristics and clinical out-
comes were compared using T-tests for continuous vari-
ables and Pearson’s chi-square for categorical variables.
To assess the effect of self-reported exercise on lon-
gitudinal changes in lung function while accounting for
confounders, we employed mixed-effects regression mod-
eling for longitudinal repeated measures with unstructured
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For longitudinal effects, we only assessed subjects over
the age of 10 years based on when rates of exercise
participation stabilized (Figure 1). Baseline FEV1, sex,
age of diagnosis, and age of questionnaire completion
were included as potential confounders as these vari-
ables differed between those who reported exercising
and those who did not (Table 1). All models used a
dependent variable of FEV1 percent predicted consisting
of all FEV1 measurements obtained over 5 years follow-
ing the time of ascertainment of exercise status (t = 0).
The independent variables were time since ascertain-
ment, exercise status, and a time-exercise interaction
term. Exercise status was defined as no exercise = 0 and
any exercise = 1 for the any exercise models and as no
competitive exercise = 0 and any competitive exercise = 1
for the competitive exercise models. All adjusted models
included the covariates of baseline FEV1 percent predicted
age at diagnosis, age at t = 0, and sex. We tested whether
different subgroups of the study sample (females, adults,
and subjects with reduced lung function) had different
changes in lung function with exercise using time-exercise-
sex, time-exercise-adult (adults being ≥18 years old), and
time-exercise-reduced lung function (reduced lung func-
tion being baseline FEV1 < 80%) interaction terms. The
interaction for sex (female = 1; male = 0) model included a
time-exercise-sex interaction term. The interaction for
age (≥18yo = 1; <18yo = 0) model included both the
term dichotomous term for age and a time-exercise-
dichotomous age interaction term. The interaction for
baseline FEV1 (≥80% = 0; <80% = 1) model included both
the term dichotomous term for baseline FEV1 and a time-
exercise-dichotomous FEV1 interaction term. P values of
less than 0.05 were considered statistically significant.
Similar analyses were performed for BMI Z-scores,Figure 1 Exercise participation vs. age. Lowess regression of
percentage of subjects reporting specific types of exercise versus
age at the time of ascertainment.except both baseline BMI Z-score and baseline FEV1
were retained as covariates. In addition, the interaction
term for time-exercise-reduced BMI Z-score was defined
by reduced BMI-Z score < 0. All analyses were performed
using Stata IC 11.0 (StataCorp LP, College Station, TX).
Results
Demographics
Of the 1038 subjects in the study sample, 774 (74.6%)
reported performing exercise and (25.4%) reported no
exercise (Table 1). For the 605 subjects over the age of
10 years at the time of exercise ascertainment, 278 (46.0%)
reported participating in any competitive exercise, 235
(38.8%) reported participating in recreational exercise
only, and 92 (15.2%) reported no exercise. As seen in
Figure 1, participation rates in any exercise increased
steadily until 10 years of age, then reached a plateau
of ~80%, which remained relatively constant in males,
but gradually decreased in females. There were no
differences in the percentage of non-white individuals
(p = 0.23) by exercise participation. There was a slight
trend to more males (53%) reporting exercise than fe-
males (47%; p = 0.07). The group that reported no exer-
cise had a younger age of diagnosis (1.5 ± 4.7 years) than
the exercise group (2.8 ± 6.0 years; p = 0.002); however,
no differences were seen with exocrine pancreatic func-
tion status (p = 0.19) or CFTR genotype (frequency of
F508del homozygotes)(p = 0.64). The group that reported
no exercise had a younger age of exercise ascertainment
(10.1 ± 11.1 years) than the exercise group (15.0 ± 9.6 years;
p < 0.001). Between countries, there were differences in the
frequency of F508del homozygotes (U.S., 45.9%; Australia,
62.2%; Israel, 0%; U.K., 21.4%; p < 0.001), frequency of
exocrine pancreatic function (U.S., 84.2%; Australia,
81.3%; Israel, 66.7%; U.K., 57.1%; p = 0.006), and age at
the time of exercise ascertainment (U.S., 14.1 years;
Australia, 8.4; Israel, 16.2; U.K., 8.3; p < 0.001), but no other
demographic differences (Additional file 1: Table S2).
Respiratory outcomes
There was no difference in the proportion of subjects
who reported wheezing with exertion between those
who did not routinely exercise (22.0%) vs. those did
(23.9%)(Table 1). Those who reported exercise had a
higher baseline FEV1 percent predicted (85.6 ± 21.5%)
than those who did not (78.0 ± 26.7%; p = 0.001). Similar
findings were seen in F508del homozygotes where those
who reported any exercise had a higher mean baseline
FEV1 (84.5 ± 21.7; n = 283) compared to the no exercise
group (73.7 ± 27.0; n = 53; p = 0.002). For the entire study
sample, there were no differences in the rates of lung
function decline in the 5 years following ascertainment
of exercise status between those who exercised vs. those
who did not.
Table 1 Study sample demographics and clinical outcomes
Mean ± S.D. [range] Entire study sample No exercise Any exercise P value
n 1038 264 774 -
Sex (% male) 51.8 47.0 53.5 0.07
Race/Ethnicity (% non-white) 9.2 11.0 8.5 0.23
(n = 1036) (n = 263) (n = 773)
Age at Diagnosis (years) 2.5 ± 5.7 1.5 ± 4.7 2.8 ± 6.0 0.002
[0, 52] [0, 51] [0, 52]
(n = 1025) (n = 259) (n = 766)
CFTR Genotype (% F508del homozygotes) 45.2 46.4 44.7 0.64
(n = 1023) (n = 263) (n = 760)
Exocrine Pancreatic Function (% insufficient) 83.3 85.9 82.4 0.19
(n = 1017) (n =256) (n = 761)
Age at Ascertainment of Exercise Status (years) 13.8 ± 10.2 10.1 ± 11.1 15.0 ± 9.6 <0.001
[0.1, 61.3] [0.1, 61.3] [1.4, 57.8]
Wheezing Reported with Exercise (% yes) 23.4 22.0 23.9 0.54
(n = 995) (n = 250) (n = 745)
Baseline FEV1 % Predicted
† 84.5 ± 22.5 78.0 ± 26.7 85.6 ± 21.5 0.001
[19.7, 145.8] [19.7, 145.8] [21.4, 137.6]
(n = 766) (n = 115) (n = 651)
Change in FEV1 % Predicted/Year
†† −1.33 ± 4.65 −0.99 ± 5.48 −1.39 ± 4.47 0.44
[−26.4, 24.3] [−26.4, 23.4] [−23.2, 24.3]
(n = 558) (n = 94) (n = 464)
Baseline BMI Z-score† −0.15 ± 0.99 −0.12 ± 1.05 −0.16 ± 0.98 0.55
[−4.72, 3.12] [−4.06, 3.12] [−4.72, 2.50]
(n = 904) (n = 207) (n = 697)
Change in BMI Z-score/Year†† −0.01 ± 0.20 0.02 ± 0.23 −0.01 ± 0.19 0.16
[−1.02, 0.83] [−1.02, 0.70] [−0.82, 0.83]
(n = 591) (n = 134) (n = 457)
†All FEV1 % predicted values were generated using U.S. CFF guidelines. All BMI Z-scores were generated using CDC percentiles. Baseline function represents the
mean of all measurements obtained within 1 year before and after the age of exercise status ascertainment.
††Change in function represents the predicted change using linear regression and all measurements obtained 5 years after the age of exercise ascertainment for
each subject. Only subjects with a minimum of 4 measurements and a minimum of 2 years of data were included.
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ences in age at the time of exercise status ascertainment,
and sex-related and age-at-diagnoses differences in exer-
cise participation, we employed mixed model regressions
including these factors as covariates. We also limited all
mixed model samples to subjects ≥10 years of age at ex-
ercise ascertainment as exercise participation rates ap-
peared to plateau after 10 years of age (Figure 1). After
these adjustments, we found that the baseline decline
in FEV1 percent predicted per year for 389 subjects
where complete data were available was −2.03% per year
(Table 2). An increase of 0.35% per year with exercise
compared to the adjusted baseline FEV1 decline was ob-
served, giving a reduced FEV1 decline of −1.68% per year
with any exercise, but this was not statistically significant(p = 0.59). We also tested several interaction terms to as-
sess whether differences in FEV1 decline with exercise
were observed by sex, age, or severity of lung disease,
more specifically to determine if certain subgroups would
be more likely to benefit from exercise. We found that ex-
ercising adults with CF (≥18 years old) would experience a
smaller decline in FEV1 (−0.50% /year) compared to exer-
cising children (10–17 years old)(−2.48% /year)(p < 0.001),
suggesting that adults may receive more of a benefit than
children from exercise (Additional file 1: Figure S1). A
graphic depiction of average lung function decline is
shown in Figure 2 for each of the three exercise groups,
showing that those reporting exercise do have higher lung
function at earlier ages with a decreased decline in adult-
hood. An interaction term for sex was not significant.
Table 2 Change in lung function with exercise with interaction term analyses (Subjects ≥ 10 years old)
Models: n = 389 subjects Estimated FEV1%
at time = 0
without exercise*
Estimated FEV1%





Change in FEV1% over
baseline per year with
exercise (p value)
Change in FEV1% over
baseline per year for
interaction (p value)
Any Exercise Unadjusted Model
(No Covariates)
74.8 82.6 (0.020) −2.01 (0.001) 0.28 (0.67) -
Adjusted Model 81.7 81.6 (0.95) −2.03 (0.001) 0.35 (0.59) -
Adjusted Model +
Interaction for Sex
81.9 81.8 (0.92) −2.03 (0.001) 0.05 (0.94) 0.67 (0.17)
Adjusted Model +
Interaction for Age









77.9 85.7 (0.001) −1.70 (<0.001) −0.16 (0.74) -
Adjusted Model 81.7 81.6 (0.98) −1.64 (<0.001) −0.18 (0.70) -
Adjusted Model +
Interaction for Sex
81.7 81.7 (0.98) −1.64 (<0.001) −0.28 (0.61) 0.22 (0.73)
Adjusted Model +
Interaction for Age




81.7 81.6 (0.93) −1.65 (<0.001) −0.49 (0.35) 0.87 (0.17)
*Estimated intercepts were calculated using the regression coefficients assuming the subject was male and had the mean values for baseline FEV1 percent
predicted (80.8 ± 22.2), age of diagnosis (3.6 ± 7.5 years), and age at time of exercise ascertainment (19.5 ± 9.4 years)(n = 389). The estimated FEV1 values are not
statistically different for the adjusted models owing to the adjustment for baseline FEV1.
Figure 2 Lung function and exercise. Average FEV1 Percent
Predicted Trajectories by Exercise Group. Lowess regression of lung
function constructed using 2 datapoints per subject (≥10 years old
at the time of exercise ascertainment), specifically the baseline FEV1
and FEV1 at the end of follow-up based on lung function decline.
Subjects were limited to these two points each to avoid overweighting
subjects with substantially more FEV1 measurements. Estimates after
40 years of age may not be as robust owing to fewer older subjects.
Although those reporting competitive exercise always appear to have
higher lung function than those reporting no exercise, those report
recreational exercise only appear to be similar to the no exercise group
between ages 10 and 20 years old, then resemble the competitive
exercise group in adulthood.
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baseline FEV1 (<80%) experienced a smaller decline in
FEV1 (−1.05%/year) compared to exercising subjects with
a baseline FEV1 ≥ 80% (−2.13%/year)(p < 0.001). We also
performed the same analysis comparing those who re-
ported any competitive exercise vs. recreational only or
no exercise to determine whether possibly more intense
exercise might result in greater benefits (Table 2). No
statistical reduction in the rate of FEV1 decline was ob-
served, except as before, competitively exercising adults
with CF (≥18 years old) would experience less of decline
in FEV1 compared to competitively exercising children
(10–17 years old)(p = 0.001).Nutritional outcomes
There were no differences in baseline BMI Z-score or
BMI Z-score change over time between those who re-
ported exercise, those who reported recreational only
exercise, and those who reported competitive exercise.
Again to account for potential confounders, we employed
mixed model regressions including the baseline BMI
Z-score, baseline FEV1, sex, age at diagnosis, and age
at the time of exercise status ascertainment as covariates.
After these adjustments, we found that the change in BMI
Z-score per year for 366 subjects ≥10 years of age where
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from zero (p = 0.08; Table 3). In addition, no statistically
significant increase or decrease in BMI Z-score was seen
with any exercise (p = 0.30). We also tested several inter-
action terms to determine whether differences in BMI
Z-scores over time with exercise were observed by sex,
age, or severity of lung disease. We found that exercis-
ing adults with CF (≥18 years old) would experience
0.08 Z-score per year increase compared to exercising
children (10–17 years old)(p = 0.001), again suggesting
that adults may receive more of a benefit than children
from exercise (Additional file 1: Figure S2). Interaction
terms for sex and baseline BMI Z-score were not sig-
nificant. As before we performed the same analysis
comparing those who reported any competitive exer-
cise vs. recreational only or no exercise (Table 3). In this
case we found that for competitively exercising subjects
with a BMI less than the 50th percentile (BMI Z-score < 0)
would experience 0.06 Z-score per year increase compared
to competitively exercising subjects with a BMI greater
than the 50th percentile (p = 0.044). Interaction terms for
sex and adulthood were not significant.
Discussion
In our questionnaire-based study we found that approxi-
mately 75% of individuals with cystic fibrosis reported
exercising on a regular basis. Exercise rates climbed
through childhood and appeared to plateau in earlyTable 3 Change in BMI Z-scores with exercise with interaction
Models: n = 366 subjects Estimated BMI
Z-score at time = 0
without exercise*
Estimated BMI Z-sc
at time = 0 with
exercise*(p value)
Any Exercise Unadjusted Model
(No Covariates)
−0.36 −0.30 (0.65)



























*Estimated intercepts were calculated using the regression coefficients assuming the s
baseline FEV1 percent predicted (80.3 ± 22.0), age of diagnosis (3.5 ± 7.2 years), and age
Z-score values are not statistically different for the adjusted models owing to the adjusadolescence, suggesting that exercise patterns may be-
come fixed during childhood for cystic fibrosis. Exercise
was associated with a higher baseline lung function, but
not BMI Z-score. Using mixed models with interaction
terms adjusted for baseline lung function, we found that
adults who reported exercising had a less rapid decline in
lung function and BMI Z-scores compared to their non-
exercising peers. We also observed that subjects with
reduced FEV1 who perform any exercise may benefit dis-
proportionately better than those with better lung func-
tion in terms of FEV1 decline. Likewise, we observed that
subjects with reduced BMI Z-scores who perform com-
petitive exercise may benefit disproportionately better
than those with better BMI Z-scores in terms of BMI
Z-score changes over time. We did not see any differ-
ences in self-reported wheezing with exertion suggest-
ing that wheezing with exertion may not be limiting
regular exercise participation or that it may be well-
controlled with medical therapy.
Although many previous randomized control trials of
aerobic exercise have not seen a significant benefit to
FEV1 with exercise, we did observe a reduced decline in
FEV1 for adults who exercised compared to those who
did not. This may be due to the fact that short-term
randomized controlled trials may be capturing the
physiological response to training, whereas our study
is attempting to capture the long-term effects of more
continuous exercise. Similar to our study, the longestterm analyses (subjects ≥ 10 years old)
ore Baseline decline
in BMI Z-score
per year (p value)
Change in BMI Z-score
over baseline per year
with exercise (p value)
Change in BMI Z-score
over baseline per year
for interaction (p value)
−0.05 (0.08) 0.03 (0.29) -
−0.05 (0.08) 0.03 (0.30) -
−0.05 (0.08) 0.02 (0.48) 0.02 (0.36)
−0.05 (0.08) 0.001 (0.98) 0.08 (0.001)
−0.05 (0.08) 0.03 (0.92) 0.04 (0.07)
−0.03 (0.025) 0.02 (0.27) -
−0.03 (0.024) 0.03 (0.25) -
−0.03 (0.024) 0.02 (0.38) 0.01 (0.80)
−0.03 (0.024) 0.005 (0.85) 0.06 (0.06)
−0.03 (0.023) −0.01 (0.68) 0.06 (0.044)
ubject was male and had the mean values for baseline BMI Z-score (−0.30 ± 0.95),
at time of exercise ascertainment (19.4 ± 9.3 years)(n = 366). The estimated BMI
tment for baseline BMI Z-scores.
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wards a decreased rate of FEV1 decline in those assigned
to the aerobic exercise group (−1.46% per year) vs.
those in the control group (−3.47% per year; p = 0.07)
[17]. Also, the effects of exercise may be accumulated
over many years, which may be why many of the ran-
domized controlled trials which predominantly enrolled
participants <18yo do not see a benefit with FEV1 or
nutritional measures, and these benefits are only ob-
served in adults in our study. An alternative hypothesis
is that children may perform a different mix of aerobic vs.
anaerobic activities than adults, which may have dif-
ferent consequences. Finally, it should be noted that
Schneiderman et al. did see and association between exer-
cise and a reduced decline in lung function among children
with cystic fibrosis, which may reflect a different means
of exercise ascertainment (HAES questionnaire) or differ-
ences in care within the study locations in Canada [22].
We did observe that females were less likely to report
performing exercise than their male counterparts start-
ing at 25–30 years old. Previously published cross-
sectional studies suggest that differences in activity levels
between sexes may occur as early as pubescence [27].
This finding may contribute to sex-specific differences in
survival observed in CF. [28,29] Although at least one
study has reported that rates of FEV1 decline were asso-
ciated with activity levels in girls, but not in boys [29],
we did not see any sex-specific benefits of exercise in
interaction modeling and the response to exercise may
be more a function of fitness rather than gender [30].
We also did not observe any differences in exercise rates
by CFTR genotype; however, CFTR genotype may play a
role in fitness level independent of lung function [31].
Strengths of this study include a well characterized
population of individuals with CF with corresponding
longitudinal phenotype data. Assessing exercise partici-
pation through a yes/no question does mimic real-world
clinical practice where time may limit the use of vali-
dated questionnaires for exercise participation. However,
assessing exercise in this categorical manner is the
primary limitation of our study and may result in an
overestimate of exercise rates. In our study sample, self-
reported exercise rates reached 80% in adolescence and
early adulthood. This compares to the 2010 CDC on
physical activity where only 64.5% of U.S. adults were
physically active as defined by ≥150 minutes/week of
moderate-intensity activity or ≥75 minutes/week of vig-
orous activity [32]. It is possible that self-reported rates
of exercise in cystic fibrosis may also be higher if exer-
cise is being used as a form of airway clearance as part
of the regular maintenance treatment regimen, but
may also represent a form of social desirability bias
when answering questionnaires. For these reasons we
also assessed the effects of competitive activity, whichmay be a less biased measure in our population as 46%
of our CF subjects over the age of 10 years reported any
competitive activity, which compares to 43.5% of the
general population reporting being highly active, which
corresponds to ≥300 minutes/week of moderate-intensity
activity or ≥150 minutes/week of vigorous activity [32].
Nevertheless, the potential misclassification bias associ-
ated self-report of exercise may lead to being underpow-
ered to detect the effects of exercise. We also had the
opportunity to assess exercise at one point in time and
our data suggests that exercise patterns may change over
time, at a minimum in young children as rates of exercise
increase during childhood. Our data also does not in-
clude any quantitative assessment of exercise intensity or
exercise types (e.g., aerobic vs. anaerobic), which could
also affect outcomes. Lastly, although we did adjust for
baseline lung function within our regression models, it is
still possible that we overestimated the benefits of exer-
cise as there may be unmeasured confounders that are
associated with higher baseline lung function that reduce
the rate of decline.
Conclusions
In conclusion, we found that adults may have more of a
benefit from regular exercise than children aged 10–17
years old, both in terms of slowing lung function decline
and preserving body mass index in CF. However, as ex-
ercise patterns may be established prior to young adult-
hood for individuals with CF, there may be some benefit
for pediatric clinicians to promote regular exercise
habits, despite the many barriers to adherence to ex-
ercise [33]. We also did not see any decline or reduced
BMI Z-scores with exercise, suggesting that individuals
with CF who exercise are likely able to increase their cal-
oric intake to meet the increased expenditures with exer-
cise. Previous studies have found that individuals with
the lowest fitness levels may see the most benefits with
exercise [30,34], and we did observe disproportionate
benefits for those with reduced FEV1 and/or reduced
BMI Z-scores. While there is a theoretical need for large
prospective studies to confirm these findings for individ-
uals with CF, we believe the longitudinal outcome bene-
fits associated with exercise outweigh the risks.
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